Medical technology company Optos has issued a trading statement revealing that it expects to make a pre-tax profit for the six-month period ending March 31.
It will be the fourth consecutive six-month period in which the company has delivered a profit.
The declaration came prior to the group's interim results which will be announced on May 21.
Half-year revenue is expected to be $48.1m to $49.1m, representing an increase of up to 22 per cent over the $40.2m revenue made by Optos during the same period last year.
Pay-per-patient revenue - where practices pay Optos each time a patient is screened by its instruments - will represent approximately 91 per cent of the group's total income for the period and continues to form the company's core business model.